Akebia Therapeutics Aktie
0,95
EUR
-0,02
EUR
-1,77
%
1,10
USD
+0,01
USD
+0,46
%
Akebia Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Akebia Therapeutics Aktie Analyse
| 06.08.19 | Akebia Therapeutics Buy | H.C. Wainwright & Co. | |
| 11.07.19 | Akebia Therapeutics Buy | H.C. Wainwright & Co. | |
| 10.08.18 | Akebia Therapeutics Buy | Needham & Company, LLC | |
| 06.06.18 | Akebia Therapeutics Buy | H.C. Wainwright & Co. | |
| 07.12.17 | Akebia Therapeutics Buy | BTIG Research | |
| 10.07.17 | Akebia Therapeutics Buy | H.C. Wainwright & Co. | |
| 27.04.17 | Akebia Therapeutics Buy | Needham & Company, LLC | |
| 27.04.17 | Akebia Therapeutics Buy | H.C. Wainwright & Co. | |
|
Werbung
|
|||
| 27.12.16 | Akebia Therapeutics Buy | H.C. Wainwright & Co. | |
| 16.03.16 | Akebia Therapeutics Buy | Needham & Company, LLC | |
| 15.12.15 | Akebia Therapeutics Buy | Needham & Company, LLC | |
| 15.12.15 | Akebia Therapeutics Buy | H.C. Wainwright & Co. | |
| 07.12.15 | Akebia Therapeutics Buy | H.C. Wainwright & Co. | |
| 14.05.15 | Akebia Therapeutics Buy | Brean Capital | |
| 11.05.15 | Akebia Therapeutics Buy | Needham & Company, LLC | |
Werbung
Werbung